Association of treatment-emergent symptoms identified by patient-reported outcomes with adjuvant endocrine therapy discontinuation

Many patients discontinue endocrine therapy for breast cancer due to intolerance. Identification of patients at risk for discontinuation is challenging. The minimal important difference (MID) is the smallest change in a score on a patient-reported outcome (PRO) that is clinically significant. We eva...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Karen Lisa, Verma, Neha, Blackford, Amanda L., Lehman, Jennifer, Westbrook, Kelly, Lim, David, Fetting, John, Wolff, Antonio C., Jelovac, Daniela, Miller, Robert S., Connolly, Roisin, Armstrong, Deborah K., Nunes, Raquel, Visvanathan, Kala, Riley, Carol, Papathakis, Katie, Zafman, Nelli, Sheng, Jennifer Y., Snyder, Claire, Stearns, Vered
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023490/
https://www.ncbi.nlm.nih.gov/pubmed/35449210
http://dx.doi.org/10.1038/s41523-022-00414-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023490/
https://www.ncbi.nlm.nih.gov/pubmed/35449210
http://dx.doi.org/10.1038/s41523-022-00414-0

Ejemplares similares